Search

Clinical Trial for Rett Syndrome Launched

Researchers at Children’s Hospital Boston have begun a randomized, placebo-controlled trial to test a potential drug treatment for Rett syndrome. The drug, mecasermin, is a synthetic form of insulin-like growth factor-1 (IGF-1). Read further details at the website of the Ontario Rett Syndrome Association.